市場調査レポート
商品コード
1344585

COVID-19診断の世界市場:技術別、製品別、チャネル別、国別予測 - エグゼクティブコンサルタントガイド付き(2023年~2027年)

COVID-19 Diagnostics. Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country. With Executive and Consultant Guides. 2023-2027

出版日: | 発行: Howe Sound Research | ページ情報: 英文 426 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
COVID-19診断の世界市場:技術別、製品別、チャネル別、国別予測 - エグゼクティブコンサルタントガイド付き(2023年~2027年)
出版日: 2023年09月02日
発行: Howe Sound Research
ページ情報: 英文 426 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のCOVID-19診断市場について調査し、市場の概要とともに、技術別、製品別、チャネル別、国別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

第3章 パンデミックの概要

  • ウイルスとは何か
  • コロナウイルス
  • パンデミックの診断

第4章 産業構造

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 計装サプライヤー
    • 薬品・試薬メーカー
    • 病理サプライヤー
    • 独立系臨床検査室
    • 公共の国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関

第5章 診断企業プロファイル

  • Abacus Diagnostica
  • Abbott Laboratories
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Access Bio
  • ADT Biotech
  • Advanced Biological Laboratories
  • Agilent/Dako
  • Altona Diagnostics
  • Alveo Technologies
  • Anatolia Geneworks
  • Anitoa
  • Antelope Dx
  • Applied BioCode
  • Applied DNA Sciences
  • Assurance Scientific Laboratories
  • Aureum Diagnostics
  • Aurora Biomed
  • Aus Diagnostics
  • Autobio Diagnostics
  • Baebies
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • BillionToOne
  • Binx Health
  • Biocartis
  • Biodesix Inc.
  • BioFire Diagnostics (bioMérieux)
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Reference Laboratories
  • Bosch Healthcare Solutions GmbH
  • Celemics
  • Cepheid (Danaher)
  • Chembio
  • Co Diagnostics
  • Color Genomics
  • CTK Biotech
  • Cue Health
  • Curetis N.V. / Curetis GmbH
  • Detect
  • Diagenode Diagnostics
  • Diasorin S.p.A.
  • Domus Diagnostics
  • Element Biosciences
  • Ellume
  • Enzo Biochem
  • Everywell
  • Fluxergy
  • Fujirebio
  • Fulgent Genetics
  • Fusion Genomics.
  • Fyr Diagnostics
  • Genedrive
  • Genetic Signatures
  • GenMark Dx (Roche)
  • Genomadix
  • Gold Standard Diagnostics
  • Hibergene Diagnostics Hologic
  • Illumina
  • Immunexpress
  • Inflammatix
  • Janssen Diagnostics
  • Karius
  • Laboratory Corporation of America
  • Letsgetchecked
  • Lexagene
  • LightDeck Diagnostics
  • Luminex (DiaSorin)
  • LumiraDx
  • Mammoth Biosciences
  • Mayo Clinic Laboratories
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech (Thermo Fisher)
  • Mesa Laboratories, Inc.
  • MicroGem
  • Minute Molecular
  • Mobidiag (Hologic)
  • Molbio Diagnostics
  • NanoDx
  • Nanomix
  • Novacyt
  • OnsiteGene
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Perkin Elmer
  • Prenetics
  • Primerdesign (Novacyt)
  • Prominex
  • Qiagen
  • QuantuMDx
  • Quest Diagnostics
  • QuidelOrtho
  • Randox Toxicology
  • Salignostics
  • Scope Fluidics
  • SD Biosensor
  • Seegene
  • Sense Biodetection
  • Sherlock Biosciences
  • Siemens Healthineers
  • Singular Genomics
  • SomaLogic
  • Sona Nanotech
  • SpeeDx
  • Talis Biomedical
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics
  • Vela Diagnostics
  • Veredus Laboratories
  • Vircell
  • Visby Medical
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第6章 最近の開発

第7章 世界のCOVID-19診断市場

  • 世界市場概要、国別
  • 世界市場- 概要、技術別
  • 世界市場- 概要、製品別
  • 世界市場- 概要、チャネル別

第8章 世界のCOVID-19診断市場- 技術別

  • PCR
  • PCRマルチプレックス
  • シーケンシング
  • 抗体
  • 抗原

第9章 世界のCOVID-19診断市場- 製品別

  • 装置
  • 試薬とキット
  • 抽出
  • 収集

第10章 世界のCOVID-19診断市場- チャネル別

  • 公共
  • 病院
  • 診療所
  • 職場
  • DTC/OTC
  • 廃水

第11章 付録

図表

Table of Tables

  • Table 1: Who List of Potential Pandemic Pathogens
  • Table 2: Characteristics of Coronavirus Pandemic Infections
  • Table 3: COVID-19 Symptoms
  • Table 4: Market Players by Type
  • Table 5: Global Market by Region
  • Table 6: Global Market by Technology
  • Table 7: Global Market by Product
  • Table 8: Global Market by Channel
  • Table 9: PCR by Country
  • Table 10: PCR Multiplex by Country
  • Table 11: Sequencing by Country
  • Table 12: Antibody by Country
  • Table 13: Antigen by Country
  • Table 14: Instruments by Country
  • Table 15: Reagents & Kits by Country
  • Table 16: Extraction by Country
  • Table 17: Collection by Country
  • Table 18: Public by Country
  • Table 19: Hospital by Country
  • Table 20: Clinic by Country
  • Table 21: Workplace by Country
  • Table 22: DTC/OTC by Country
  • Table 23: Wastewater by Country
  • Table 24: Approved Covid-19 Assays

Table of Figures

  • Figure 1: Global Distribution Pandemic Preparedness
  • Figure 2: Global Pandemic Pathogen Status
  • Figure 3: Estimated Economic Impact of Viral Pandemic by Region
  • Figure 4: Historical Pandemics Infographic
  • Figure 5: Antigenic Drift Creates a new Strain of Virus
  • Figure 6: Structure of Coronaviruses
  • Figure 7: The Road to Diagnostics
  • Figure 8: Global Market Share Chart
  • Figure 9: Base/Final Year Comparison Chart
  • Figure 10: Global Markets by Technology Base Year
  • Figure 11: Global Markets by Technology End Year
  • Figure 12: Global Markets by Technology Share by Year
  • Figure 13: Global Markets by Technology Segment Growth
  • Figure 14: Global Market by Product Base vs. Final
  • Figure 15: Global Market by Product Base Year
  • Figure 16: Global Market by Product End Year
  • Figure 17: Global Market by Product Share by Year
  • Figure 18: Global Market by Product Segments Growth
  • Figure 19: global Market by Channel - Base vs. Final
  • Figure 20: global Market by Channel - Base Year
  • Figure 21: global Market by Channel - End Year
  • Figure 22: global Market by Channel - Share by Year
  • Figure 23: global Market by Channel - Segments Growth
  • Figure 24: PCR Growth
  • Figure 25: PCR Multiplex Growth
  • Figure 26: Sequencing Growth
  • Figure 27: Antibody Growth
  • Figure 28: Antigen Growth
  • Figure 29: Instruments Growth
  • Figure 30: Reagents & Kits Growth
  • Figure 31: Extraction Growth
  • Figure 32: Collection Growth
  • Figure 33: Public Growth
  • Figure 34: Hospital Growth
  • Figure 35: Clinic Growth
  • Figure 36: Workplace Growth
  • Figure 37: DTC/OTC Growth
  • Figure 38: Wastewater Growth
目次

OVERVIEW:

The pandemic may be over but COVID-19 is here to stay. Multiple competitors are vying for the very lucrative future for respiratory diagnostics.

New variants and the situation in China have changed the pandemic outlook. And we have changed ours. Get the revised outlook based on the latest data. A new dynamic market is emerging for Covid - 19 based diagnostics. Testing is moving into physicians' offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the Workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, technology, products and channels. They are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with our Market Guides and Situation Analysis.

All report data is available in Excel format on request.

Make projections with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guidance for Executives
  • 1.3. Guidance for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What are Pandemics?
  • 2.2. The Role of Zoonosis
  • 2.3. Market Definition
    • 2.3.1. PCR
    • 2.3.2. PCR Multiplex
    • 2.3.3. SEQ
    • 2.3.4. Antigen
    • 2.3.5. Antibodies
    • 2.3.6. Instruments
    • 2.3.7. Reagents and Kits
    • 2.3.8. Extract
    • 2.3.9. Collect
    • 2.3.10. Public
    • 2.3.11. Hospital
    • 2.3.12. Clinic
    • 2.3.13. Workplace
    • 2.3.14. DTC/OTC
    • 2.3.15. Wastewater
  • 2.4. Methodology
    • 2.4.1. Sources
    • 2.4.2. Authors
  • 2.5. Historical Perspective on Pandemics
    • 2.5.1. HIV/AIDS PANDEMIC 2005-2012
    • 2.5.2. FLU PANDEMIC 1968
    • 2.5.3. ASIAN FLU 1956-1958
    • 2.5.4. SPANISH FLU 1918
    • 2.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
    • 2.5.6. FLU PANDEMIC 1889-1890
    • 2.5.7. THE BLACK DEATH 1346-1353

3. The Pandemic Overview

  • 3.1. What is a Virus?
    • 3.1.1. Is a Virus Alive?
    • 3.1.2. Viral Structure
    • 3.1.3. The Viral Genome
    • 3.1.4. Viral Mutation
  • 3.2. The Coronavirus
    • 3.2.1. Severe acute respiratory syndrome (SARS)
    • 3.2.2. Middle East respiratory syndrome (MERS)
    • 3.2.3. COVID-19. The SARS CoV 2 Virus.
      • 3.2.3.1. Signs and symptoms
      • 3.2.3.2. Transmission
      • 3.2.3.3. Diagnosis
      • 3.2.3.4. Prevention
      • 3.2.3.5. Management
      • 3.2.3.6. Prognosis
      • 3.2.3.7. A Note on Global Statistics Reporting
  • 3.3. Pandemic Diagnostics
    • 3.3.1. Risk Management - Spark and Spread
    • 3.3.2. Dx Technology - Nucleic Acid Based
    • 3.3.3. Dx Technology-Immunoassay
    • 3.3.4. Time to Market and Preparedness Issues

4. Industry Structure

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Instrumentation Supplier
    • 4.1.4. Chemical/Reagent Supplier
    • 4.1.5. Pathology Supplier
    • 4.1.6. Independent Clinical Laboratory
    • 4.1.7. Public National/regional Laboratory
    • 4.1.8. Hospital Laboratory
    • 4.1.9. Physicians Office Lab (POLS)
    • 4.1.10. Audit Body
    • 4.1.11. Certification Body

5. Diagnostic Company Profiles

  • 5.1. Abacus Diagnostica
  • 5.2. Abbott Laboratories
  • 5.3. Accel Diagnostics
  • 5.4. Accelerate Diagnostics
  • 5.5. Access Bio
  • 5.6. ADT Biotech
  • 5.7. Advanced Biological Laboratories
  • 5.8. Agilent/Dako
  • 5.9. Altona Diagnostics
  • 5.10. Alveo Technologies
  • 5.11. Anatolia Geneworks
  • 5.12. Anitoa
  • 5.13. Antelope Dx
  • 5.14. Applied BioCode
  • 5.15. Applied DNA Sciences
  • 5.16. Assurance Scientific Laboratories
  • 5.17. Aureum Diagnostics
  • 5.18. Aurora Biomed
  • 5.19. Aus Diagnostics
  • 5.20. Autobio Diagnostics
  • 5.21. Baebies
  • 5.22. Beckman Coulter Diagnostics
  • 5.23. Becton, Dickinson and Company
  • 5.24. BGI Genomics Co. Ltd
  • 5.25. BillionToOne
  • 5.26. Binx Health
  • 5.27. Biocartis
  • 5.28. Biodesix Inc.
  • 5.29. BioFire Diagnostics (bioMérieux)
  • 5.30. Biolidics Ltd
  • 5.31. bioMérieux Diagnostics
  • 5.32. Bioneer Corporation
  • 5.33. Bio-Rad Laboratories, Inc
  • 5.34. Bio-Reference Laboratories
  • 5.35. Bosch Healthcare Solutions GmbH
  • 5.36. Celemics
  • 5.37. Cepheid (Danaher)
  • 5.38. Chembio
  • 5.39. Co Diagnostics
  • 5.40. Color Genomics
  • 5.41. CTK Biotech
  • 5.42. Cue Health
  • 5.43. Curetis N.V. / Curetis GmbH
  • 5.44. Detect
  • 5.45. Diagenode Diagnostics
  • 5.46. Diasorin S.p.A.
  • 5.47. Domus Diagnostics
  • 5.48. Element Biosciences
  • 5.49. Ellume
  • 5.50. Enzo Biochem
  • 5.51. Everywell
  • 5.52. Fluxergy
  • 5.53. Fujirebio
  • 5.54. Fulgent Genetics
  • 5.55. Fusion Genomics.
  • 5.56. Fyr Diagnostics
  • 5.57. Genedrive
  • 5.58. Genetic Signatures
  • 5.59. GenMark Dx (Roche)
  • 5.60. Genomadix
  • 5.61. Gold Standard Diagnostics
  • 5.62. Hibergene Diagnostics
  • 5.63. Hologic
  • 5.64. Illumina
  • 5.65. Immunexpress
  • 5.66. Inflammatix
  • 5.67. Janssen Diagnostics
  • 5.68. Karius
  • 5.69. Laboratory Corporation of America
  • 5.70. Letsgetchecked
  • 5.71. Lexagene
  • 5.72. LightDeck Diagnostics
  • 5.73. Luminex (DiaSorin)
  • 5.74. LumiraDx
  • 5.75. Mammoth Biosciences
  • 5.76. Mayo Clinic Laboratories
  • 5.77. Mbio Diagnostics
  • 5.78. Meridian Bioscience
  • 5.79. Mesa Biotech (Thermo Fisher)
  • 5.80. Mesa Laboratories, Inc.
  • 5.81. MicroGem
  • 5.82. Minute Molecular
  • 5.83. Mobidiag (Hologic)
  • 5.84. Molbio Diagnostics
  • 5.85. NanoDx
  • 5.86. Nanomix
  • 5.87. Novacyt
  • 5.88. OnsiteGene
  • 5.89. OraSure Technologies
  • 5.90. Oxford Nanopore Technologies
  • 5.91. Perkin Elmer
  • 5.92. Prenetics
  • 5.93. Primerdesign (Novacyt)
  • 5.94. Prominex
  • 5.95. Qiagen
  • 5.96. QuantuMDx
  • 5.97. Quest Diagnostics
  • 5.98. QuidelOrtho
  • 5.99. Randox Toxicology
  • 5.100. Salignostics
  • 5.101. Scope Fluidics
  • 5.102. SD Biosensor
  • 5.103. Seegene
  • 5.104. Sense Biodetection
  • 5.105. Sherlock Biosciences
  • 5.106. Siemens Healthineers
  • 5.107. Singular Genomics
  • 5.108. SomaLogic
  • 5.109. Sona Nanotech
  • 5.110. SpeeDx
  • 5.111. Talis Biomedical
  • 5.112. Thermo Fisher Scientific Inc.
  • 5.113. Ultima Genomics
  • 5.114. Vela Diagnostics
  • 5.115. Veredus Laboratories
  • 5.116. Vircell
  • 5.117. Visby Medical
  • 5.118. YD Diagnostics
  • 5.119. Zhejiang Orient Gene Biotech

6. Covid-19 Diagnostics Recent Developments

  • 6.1. Recent Developments - Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Labcorp Gets Approval for Sequencing-Based COVID Test
  • 6.3. Post-Pandemic, Patients Savvy About ID Diagnostics
  • 6.4. Discover Labs Obtains EUA for RT-PCR COVID Test
  • 6.5. Sensible Dx to Launch 10-Minute POC PCR System
  • 6.6. Aptitude Medical Systems Aiming for At-Home Market
  • 6.7. Qorvo To Emerge as More Than a COVID Company
  • 6.8. End of COVID-19 Emergency Lowers Diagnostics Revenue
  • 6.9. FDA Issues EUA for GenBody At-Home COVID Test
  • 6.10. CTK Biotech Gets EAU for At-Home COVID Antigen Test
  • 6.11. FDA Grants EAU for Premier Medical At-Home COVID Assay
  • 6.12. QuidelOrtho Seeks Home Testing Contract
  • 6.13. Aptitude Medical Gets EUA for Over-the-Counter COVID Saliva MDx
  • 6.14. Siemens Healthineers Gains CE Marks for Seasonal Viral Assays
  • 6.15. NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
  • 6.16. North American Dx Recalls Covid Rapid Antigen Tests
  • 6.17. Domus Dx to Launch OC Diagnostics Test System
  • 6.18. Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
  • 6.19. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
  • 6.20. At-Home COVID Test Coverage
  • 6.21. LuminUltra Wins 500-Site CDC Wastewater Testing Contract
  • 6.22. Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
  • 6.23. Tests Called Back
  • 6.24. Cepheid Obtains CE Mark for Expanded Combo COVID Test
  • 6.25. CRISPR Tests for SARS-CoV-2 Using Saliva Samples
  • 6.26. CVS Limits Purchases of Rapid Covid-19 Tests
  • 6.27. Illumina, COVID-19 Surveillance Continue to Boost Business
  • 6.28. LetsGetChecked Closes $150M Funding Round
  • 6.29. Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
  • 6.30. Abbott Sees Sharp Decline in COVID-19 Test Revenue
  • 6.31. Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
  • 6.32. NY Times Explores Multiplex Testing
  • 6.33. Hologic Banking on MDx Acquisitions
  • 6.34. Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022
  • 6.35. DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
  • 6.36. LumiraDx to Go Public Through SPAC
  • 6.37. Eurofins Test Helps to ID Mutations
  • 6.38. Roche Sees Growing Opportunities for Diagnostics
  • 6.39. Roche to Acquire GenMark Diagnostics for $1.8B
  • 6.40. Fulgent Genetics s to Use COVID-19 Testing Gains to Grow Clinical Sequencing
  • 6.41. LexaGene Syndromic Panel Platform Lets Labs Customize Targets
  • 6.42. FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests
  • 6.43. At-Home Infectious Disease Test Developer Lucira Health Goes Public

7. The Global Market for COVID-19 Diagnostics

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart-Global Market by Country
  • 7.2. Global Market by Technology-Overview
    • 7.2.1. Table - Global Market by Technology
    • 7.2.2. Chart - Global Market by Technology - Base/Final Year Comparison
    • 7.2.3. Chart - Global Market by Technology - Base Year
    • 7.2.4. Chart - Global Market by Technology - End Year
    • 7.2.5. Chart - Global Market by Technology - Share by Year
    • 7.2.6. Chart - Global Market by Technology - Segments Growth
  • 7.3. Global Market by Product-Overview
    • 7.3.1. Table - Global Market by Product
    • 7.3.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 7.3.3. Chart - Global Market by Product - Base Year
    • 7.3.4. Chart - Global Market by Product - End Year
    • 7.3.5. Chart - Global Market by Product - Share by Year
    • 7.3.6. Chart - Global Market by Product - Segments Growth
  • 7.4. Global Market by Channel-Overview
    • 7.4.1. Table - Global Market by Channel
    • 7.4.2. Chart - Global Market by Channel - Base/Final Year Comparison
    • 7.4.3. Chart - Global Market by Channel - Base Year
    • 7.4.4. Chart - Global Market by Channel - End Year
    • 7.4.5. Chart - Global Market by Channel - Share by Year
    • 7.4.6. Chart - Global Market by Channel - Segments Growth

8. Global COVID-19 Diagnostic Markets - By Technology

  • 8.1. PCR
    • 8.1.1. Table PCR - by Country
    • 8.1.2. Chart-PCR Growth
  • 8.2. PCR Multiplex
    • 8.2.1. Table PCR Multiplex - by Country
    • 8.2.2. Chart-PCR Multiplex Growth
  • 8.3. Sequencing
    • 8.3.1. Table Sequencing - by Country
    • 8.3.2. Chart-Sequencing Growth
  • 8.4. Antibody
    • 8.4.1. Table Antibody - by Country
    • 8.4.2. Chart-Antibody Growth
  • 8.5. Antigen
    • 8.5.1. Table Antigen - by Country
    • 8.5.2. Chart - Antigen Growth

9. Global COVID-19 Diagnostic Markets - By Product

  • 9.1. Instruments
    • 9.1.1. Table Instruments - by Country
    • 9.1.2. Chart-Instruments Growth
  • 9.2. Reagents & Kits
    • 9.2.1. Table Reagents & Kits - by Country
    • 9.2.2. Chart - Reagents & Kits Growth
  • 9.3. Extraction
    • 9.3.1. Table Extraction - by Country
    • 9.3.2. Chart-Extraction Growth
  • 9.4. Collection
    • 9.4.1. Table Collection - by Country
    • 9.4.2. Chart-Collection Growth

10. Global COVID-19 Diagnostic Markets - By Channel

  • 10.1. Public
    • 10.1.1. Table Public - by Country
    • 10.1.2. Chart-Public Growth
  • 10.2. Hospital
    • 10.2.1. Table Hospital - by Country
    • 10.2.2. Chart-Hospital Growth
  • 10.3. Clinic
    • 10.3.1. Table Clinic - by Country
    • 10.3.2. Chart-Clinic Growth
  • 10.4. Workplace
    • 10.4.1. Table Workplace - by Country
    • 10.4.2. Chart-Workplace Growth
  • 10.5. DTC/OTC
    • 10.5.1. Table DTC/OTC - by Country
    • 10.5.2. Chart - DTC/OTC Growth
  • 10.6. Wastewater
    • 10.6.1. Table Wastewater - by Country
    • 10.6.2. Chart - Wastewater Growth

11. Appendix

  • 11.1. U.S., Europe, Asia Approved COVID-19 Assays